306 related articles for article (PubMed ID: 27242166)
21. Comprehensive mapping of a novel NS1 epitope conserved in flaviviruses within the Japanese encephalitis virus serocomplex.
Hua RH; Liu LK; Huo H; Li YN; Guo LP; Wang XL; Qin CF; Bu ZG
Virus Res; 2014 Jun; 185():103-9. PubMed ID: 24631788
[TBL] [Abstract][Full Text] [Related]
22.
Saron WAA; Rathore APS; Ting L; Ooi EE; Low J; Abraham SN; St John AL
Sci Adv; 2018 Jul; 4(7):eaar4297. PubMed ID: 29978039
[TBL] [Abstract][Full Text] [Related]
23. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination.
Shu PY; Chen LK; Chang SF; Yueh YY; Chow L; Chien LJ; Chin C; Lin TH; Huang JH
Vaccine; 2001 Feb; 19(13-14):1753-63. PubMed ID: 11166901
[TBL] [Abstract][Full Text] [Related]
24. Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.
Ishikawa T; Wang G; Widman DG; Infante E; Winkelmann ER; Bourne N; Mason PW
Vaccine; 2011 Oct; 29(43):7444-55. PubMed ID: 21798299
[TBL] [Abstract][Full Text] [Related]
25. Structural Study of the C-Terminal Domain of Nonstructural Protein 1 from Japanese Encephalitis Virus.
Poonsiri T; Wright GSA; Diamond MS; Turtle L; Solomon T; Antonyuk SV
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343583
[TBL] [Abstract][Full Text] [Related]
26. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P
Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
[TBL] [Abstract][Full Text] [Related]
27. Lack of Interferon (IFN) Regulatory Factor 8 Associated with Restricted IFN-γ Response Augmented Japanese Encephalitis Virus Replication in the Mouse Brain.
Tripathi A; Singh Rawat B; Addya S; Surjit M; Tailor P; Vrati S; Banerjee A
J Virol; 2021 Oct; 95(21):e0040621. PubMed ID: 34379515
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of Japanese encephalitis virus-specific, human CD4(+) T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity.
Aihara H; Takasaki T; Matsutani T; Suzuki R; Kurane I
J Virol; 1998 Oct; 72(10):8032-6. PubMed ID: 9733842
[TBL] [Abstract][Full Text] [Related]
29. Japanese encephalitis virus-primed CD8+ T cells prevent antibody-dependent enhancement of Zika virus pathogenesis.
Chen D; Duan Z; Zhou W; Zou W; Jin S; Li D; Chen X; Zhou Y; Yang L; Zhang Y; Shresta S; Wen J
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32501510
[TBL] [Abstract][Full Text] [Related]
30. Co-positivity of anti-dengue virus and anti-Japanese encephalitis virus IgM in endemic area: co-infection or cross reactivity?
Singh KP; Mishra G; Jain P; Pandey N; Nagar R; Gupta S; Prakash S; Prakash O; Khan DN; Shrivastav S; Singh DD; Jain A
Asian Pac J Trop Med; 2014 Feb; 7(2):124-9. PubMed ID: 24461525
[TBL] [Abstract][Full Text] [Related]
31. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection.
Kao YS; Yu CY; Huang HJ; Tien SM; Wang WY; Yang M; Anderson R; Yeh TM; Lin YS; Wan SW
J Immunol; 2019 Oct; 203(7):1909-1917. PubMed ID: 31451673
[TBL] [Abstract][Full Text] [Related]
32. Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine.
Lima NS; Moon D; Darko S; De La Barrera RA; Lin L; Koren MA; Jarman RG; Eckels KH; Thomas SJ; Michael NL; Modjarrad K; Douek DC; Trautmann L
Front Immunol; 2021; 12():640190. PubMed ID: 33717194
[TBL] [Abstract][Full Text] [Related]
33. Blockage of indoleamine 2,3-dioxygenase regulates Japanese encephalitis via enhancement of type I/II IFN innate and adaptive T-cell responses.
Kim SB; Choi JY; Uyangaa E; Patil AM; Hossain FM; Hur J; Park SY; Lee JH; Kim K; Eo SK
J Neuroinflammation; 2016 Apr; 13(1):79. PubMed ID: 27090635
[TBL] [Abstract][Full Text] [Related]
34. Establishment of an Algorithm Using prM/E- and NS1-Specific IgM Antibody-Capture Enzyme-Linked Immunosorbent Assays in Diagnosis of Japanese Encephalitis Virus and West Nile Virus Infections in Humans.
Galula JU; Chang GJ; Chuang ST; Chao DY
J Clin Microbiol; 2016 Feb; 54(2):412-22. PubMed ID: 26659204
[TBL] [Abstract][Full Text] [Related]
35. Identification of a protective epitope in Japanese encephalitis virus NS1 protein.
Zhou D; Pei C; Liu Z; Yang K; Li Q; Chen H; Cao S; Song Y
Antiviral Res; 2020 Oct; 182():104930. PubMed ID: 32898585
[TBL] [Abstract][Full Text] [Related]
36. Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates.
Konishi E; Kurane I; Mason PW; Shope RE; Kanesa-Thasan N; Smucny JJ; Hoke CH; Ennis FA
Vaccine; 1998 May; 16(8):842-9. PubMed ID: 9627942
[TBL] [Abstract][Full Text] [Related]
37. PD1
Zhang F; Qi L; Li T; Li X; Yang D; Cao S; Ye J; Wei B
Virol Sin; 2019 Oct; 34(5):538-548. PubMed ID: 31215000
[TBL] [Abstract][Full Text] [Related]
38. Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus.
Lobigs M; Larena M; Alsharifi M; Lee E; Pavy M
J Virol; 2009 Mar; 83(6):2436-45. PubMed ID: 19109382
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody-based antigen capture immunoassay for detection of circulating non-structural protein NS1: implications for early diagnosis of Japanese encephalitis virus infection.
Kumar JS; Parida M; Rao PV
J Med Virol; 2011 Jun; 83(6):1063-70. PubMed ID: 21503922
[TBL] [Abstract][Full Text] [Related]
40. The C Terminus of the Core β-Ladder Domain in Japanese Encephalitis Virus Nonstructural Protein 1 Is Flexible for Accommodation of Heterologous Epitope Fusion.
Yen LC; Liao JT; Lee HJ; Chou WY; Chen CW; Lin YL; Liao CL
J Virol; 2016 Feb; 90(3):1178-89. PubMed ID: 26559836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]